/WAT
Waters Corporation
WAT • NYSEWAT • NYSE • Healthcare
$286.57+1.15%+3.25
$286.57+1.15%(+3.25)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
72Low Risk
Momentum
16Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
57.8%▼1.7pp
Revenue after COGS
Operating
28.2%▲0.3pp
After operating expenses
Net
20.3%▼1.3pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
35.2
Price vs earnings
EV/EBITDA
23.1
Enterprise value
FCF Yield
2.4%
Cash generation
Earnings Yield
2.8%
Inverse of P/E
Capital Efficiency
18
GoAI Quality ScoreStrong
ROEReturn on Equity
25.1%Strong
ROAReturn on Assets
12.6%Strong
ROICReturn on Invested Capital
15.0%Strong
Financial Health
Current RatioWeak
0.00
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
0.81x
Debt repayment capacity (<3x)
Income QualityStrong
1.02
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.17B | $2.96B | $2.96B | $2.97B | $2.79B |
| Gross Profit | $1.83B | $1.76B | $1.76B | $1.72B | $1.63B |
| Gross Margin | 57.8% | 59.4% | 59.6% | 58.0% | 58.5% |
| Operating Income | $893.22M | $826.35M | $817.68M | $873.39M | $821.71M |
| Net Income | $642.63M | $637.83M | $642.23M | $707.75M | $692.84M |
| Net Margin | 20.3% | 21.6% | 21.7% | 23.8% | 24.9% |
| EPS | $10.80 | $10.75 | $10.87 | $11.80 | $11.25 |
Average Price Target
$401.00▲ 39.9% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for Waters Corporation, the average price target is $401.00, with a high forecast of $480.00 and a low forecast of $350.00. The average price target represents a 39.9% increase from the current price of $286.57.
Highest
$480.00
Average
$401.00
Lowest
$350.00
Rating Distribution
Strong Buy
0
0%
Buy
10
29%
Hold
21
62%
Sell
3
9%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Morgan Stanley● Maintain
Equal Weight
2026-02-23Wells Fargo● Maintain
Equal Weight
2026-02-11B of A Securities● Maintain
Neutral
2026-02-10UBS● Maintain
Neutral
2026-02-10Guggenheim● Maintain
Buy
2026-02-10Wells Fargo● Maintain
Equal Weight
2025-12-15Wolfe Research▲ Upgrade
Peer Perform→Outperform
2025-12-10TD Cowen● Maintain
Hold
2025-11-05Wells Fargo● Maintain
Equal Weight
2025-11-05JP Morgan● Maintain
Neutral
2025-10-09Earnings History & Surprises
BEAT RATE
94%
Last 18 quarters
AVG SURPRISE
+5.1%
EPS vs Estimate
BEATS / MISSES
17/1
Last 18 quarters
LATEST EPS
$4.53
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+0.4%
$4.53 vs $4.51
Q4 '25
+5.9%
$3.40 vs $3.21
Q3 '25
+0.3%
$2.95 vs $2.94
Q2 '25
+1.4%
$2.25 vs $2.22
Q1 '25
+1.7%
$4.10 vs $4.03
Q4 '24
+9.3%
$2.93 vs $2.68
Q3 '24
+2.7%
$2.63 vs $2.56
Q2 '24
+5.2%
$2.21 vs $2.10
Q1 '24
+2.0%
$3.62 vs $3.55
Q4 '23
+11.4%
$2.84 vs $2.55
Q3 '23
+8.1%
$2.80 vs $2.59
Q2 '23
-4.6%
$2.49 vs $2.61
No investor questions available.
Latest News
No news available